MannKind Corp (MNKD)

S&amp;P 500: 1,262.90
Change: 0.11%

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Recs

Avatar EclecticRecluse (72.62) Submitted: 5/11/08 11:32 AM : Start Price: $2.43 MNKD Score: 22.56

Short Term Bounce Expected

Featured Broker Partners